These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27425417)

  • 1. Silver nitrate for Kaposi's sarcoma nodules: A new look at an old treatment.
    Brambilla L; Tourlaki A
    J Dermatolog Treat; 2017 Mar; 28(2):152-154. PubMed ID: 27425417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
    Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
    Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic Kaposi's sarcoma: low-dose interferon alfa treatment.
    Tur E; Brenner S
    Dermatology; 1998; 197(1):37-42. PubMed ID: 9693183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic Kaposi's sarcoma treated with topical rapamycin.
    Díaz-Ley B; Grillo E; Ríos-Buceta L; Paoli J; Moreno C; Vano-Galván S; Jaén-Olasolo P
    Dermatol Ther; 2015; 28(1):40-3. PubMed ID: 25314592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.
    Turk HM; Buyukberber S; Camci C; Inaloz HS; Sari I; Kirtak N; Uner A
    J Dermatol; 2002 Oct; 29(10):657-60. PubMed ID: 12432999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.
    Di Monta G; Caracò C; Benedetto L; La Padula S; Marone U; Tornesello ML; Buonaguro FM; Simeone E; Ascierto PA; Mozzillo N
    Eur J Surg Oncol; 2014 Jan; 40(1):61-6. PubMed ID: 24075826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of silver nitrate cauterization for pyogenic granuloma of the hand.
    Quitkin HM; Rosenwasser MP; Strauch RJ
    J Hand Surg Am; 2003 May; 28(3):435-8. PubMed ID: 12772100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
    Alcántara-Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Vélez García-Nieto A
    Dermatol Ther; 2016 Sep; 29(5):309-311. PubMed ID: 27329079
    [No Abstract]   [Full Text] [Related]  

  • 10. Imiquimod for the treatment of classical Kaposi's sarcoma.
    Bernardini B; Faggion D; Calabró L; Oro E; Alaibac M
    Acta Derm Venereol; 2010 Jul; 90(4):417-8. PubMed ID: 20574613
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
    Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
    Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients.
    Brambilla L; Recalcati S; Tourlaki A
    Eur J Dermatol; 2015; 25(6):535-8. PubMed ID: 26552718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib-induced regression of AIDS-related Kaposi's sarcoma.
    Koon HB; Bubley GJ; Pantanowitz L; Masiello D; Smith B; Crosby K; Proper J; Weeden W; Miller TE; Chatis P; Egorin MJ; Tahan SR; Dezube BJ
    J Clin Oncol; 2005 Feb; 23(5):982-9. PubMed ID: 15572730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal and cutaneous AIDS-related Kaposi's sarcoma: different activity of liposomal doxorubicin according to location of lesions.
    Hernández-Morales DE; Hernández-Zaccaro AE
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):264-6. PubMed ID: 15952971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited extent AIDS-related cutaneous Kaposi's sarcoma responsive to imiquimod 5% cream.
    Rosen T
    Int J Dermatol; 2006 Jul; 45(7):854-6. PubMed ID: 16863526
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study.
    Scolaro MJ; Gunnill LB; Pope LE; Khalil MH; Katz DH; Berg JE
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):35-43. PubMed ID: 11177381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended surgery of Kaposi's sarcoma nodules.
    Tourlaki A; Bellinvia M; Brambilla L
    J Dermatolog Treat; 2015; 26(4):354-6. PubMed ID: 25283737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.